Steady-state model for plasma free and platelet serotonin in man.

[1]  D. Cohen,et al.  Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate. , 1987, Life sciences.

[2]  J. Rapoport,et al.  Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder. , 1987, Archives of general psychiatry.

[3]  J. Feldman.  Urinary serotonin in the diagnosis of carcinoid tumors. , 1986, Clinical chemistry.

[4]  M. Sole,et al.  An active pathway for serotonin synthesis by renal proximal tubules. , 1986, Kidney international.

[5]  B. Pitt,et al.  Pulmonary metabolic function in the awake lamb: effect of development and hypoxia. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[6]  C. N. Gillis,et al.  Comparison of pulmonary and extrapulmonary extraction of biogenic amines. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[7]  H. Meltzer,et al.  A modified assay method for determining serotonin uptake in human platelets. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[8]  R. Dedrick,et al.  Nonlinear pharmacokinetic models for 5‐fluorouracil in man: Intravenous and intraperitoneal routes , 1980, Clinical pharmacology and therapeutics.

[9]  C. N. Gillis,et al.  Pulmonary clearance of [14C]-5-hydroxytryptamine and [3H]norepinephrine in vivo: effects of pretreatment with imipramine or cocaine. , 1980, The Journal of pharmacology and experimental therapeutics.

[10]  L. Landsberg,et al.  Excretion and metabolism of catecholamines by the isolated perfused rat kidney. , 1979, The Journal of clinical investigation.

[11]  C. N. Gillis,et al.  Indicator dilution measurement of 5-hydroxytryptamine clearance by human lung. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.

[12]  D. Murphy,et al.  Maximal packet size for serotonin in storage vesicles of intact human platelets. , 1978, Life sciences.

[13]  C. N. Gillis,et al.  EFFECTS OF MONOCROTALINE PRETREATMENT OF RATS ON REMOVAL OF 5‐HYDROXYTRYPTAMINE AND NORADRENALINE BY PERFUSED LUNG , 1978, British journal of pharmacology.

[14]  S. Stahl.  The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. , 1977, Archives of general psychiatry.

[15]  L. Wetterberg,et al.  Decreased blood level of 5-dehydroxytryptamine by inhibitors of the membranal 5-hydroxytryptamine uptake. , 1976, Life sciences.

[16]  N. M. Greene,et al.  Removal of 5-hydroxytryptamine and norepinephrine from the pulmonary vascular space of man: influence of cardiopulmonary bypass and pulmonary arterial pressure on these processes. , 1974, Surgery.

[17]  A. Junod.  Uptake, metabolism and efflux of 14 C-5-hydroxytryptamine in isolated perfused rat lungs. , 1972, The Journal of pharmacology and experimental therapeutics.

[18]  R. Groszmann,et al.  Circulation times in the splanchnic and hepatic beds in alcoholic liver disease. , 1972, Gastroenterology.

[19]  N. M. Greene,et al.  Pulmonary Extraction of 5‐Hydroxytryptamine and Norepinephrine before and after Cardiopulmonary Bypass in Man , 1972, Circulation research.

[20]  Y. S. Bakhle,et al.  Removal of 5‐hydroxytryptamine in the pulmonary circulation of rat isolated lungs , 1970, British journal of pharmacology.

[21]  B. Rennick,et al.  Effects of structural modifications of catecholamines on renal tubular transport in the chicken. , 1969, The Journal of pharmacology and experimental therapeutics.

[22]  N. Crawford.  Serotonin absorption by normal and "carcinoid" platelets. , 1967, Clinica chimica acta; international journal of clinical chemistry.

[23]  J. Vane,et al.  5-Hydroxytryptamine in the Circulation of the Dog , 1967, Nature.

[24]  B. Wortman,et al.  Tubular excretion of serotonin (5-hydroxytryptamine) in the chicken. , 1962, Acta physiologica Scandinavica.

[25]  R. Heyssel.  Determination of human platelet survival utilizing C-14-labeled serotonin. , 1961, The Journal of clinical investigation.

[26]  V. Erspamer,et al.  Observations on the Release and Turnover Rate of 5‐Hydroxytryptamine in the Gastrointestinal Tract , 1959, The Journal of pharmacy and pharmacology.

[27]  B. Haverback,et al.  Serotonin and the gastrointestinal tract. , 1958, Gastroenterology.

[28]  H. Weissbach,et al.  The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay. , 1955, The Journal of biological chemistry.

[29]  C. Toh,et al.  Release of 5‐hydroxytryptamine (serotonin) from the dog's gastro‐intestinal tract , 1954, The Journal of physiology.

[30]  D. Cohen,et al.  Effect of a meal on human whole blood serotonin. , 1985, Gastroenterology.

[31]  D. Cohen,et al.  Two-dimensional high-performance liquid chromatographic determination of 5-hydroxyindoleacetic acid and homovanillic acid in urine. , 1985, Analytical biochemistry.

[32]  R. Roth,et al.  Clearance of 5-hydroxytryptamine by rat lung and liver: the importance of relative perfusion and intrinsic clearance. , 1980, The Journal of pharmacology and experimental therapeutics.

[33]  Huang Kc,et al.  Renal excretion of D-tryptophan, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in rats. , 1973 .

[34]  W. Lovenberg,et al.  In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition. , 1961, The Journal of pharmacology and experimental therapeutics.